🇺🇸 FDA
Patent

US 8269013

Substituted pyrazole inhibitors of c-Met protein kinase

granted A61PA61P29/00A61P35/00

Quick answer

US patent 8269013 (Substituted pyrazole inhibitors of c-Met protein kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P29/00, A61P35/00, A61P35/04, A61P43/00